Strength
50 ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173052100
Classification
Brand
Dosage Form
POWDER, METERED
Route
ORAL; RESPIRATORY (INHALATION)
Last Updated
4/22/2026
Active Ingredients
SALMETEROL XINAFOATEApproval Type
New Drug (NDA)
FDA Application
NDA020692On Market Since
11/25/1997
Pharmacological Classes
Adrenergic beta2-Agonists
beta2-Adrenergic Agonist
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
ADVAIR 100-50 DISKUS
Brand
00173069500•GlaxoSmithKline LLC
$2.4867
per EA
VENTOLIN HFA 90 MCG INHALER
Brand
00173068224•GlaxoSmithKline LLC
$2.7222
per GM
VENTOLIN HFA 90 MCG INHALER
Brand
00173068220•GlaxoSmithKline LLC
$3.0358
per GM
ADVAIR 250-50 DISKUS
Brand
00173069604•GlaxoSmithKline LLC
$3.1083
per EA
ADVAIR 250-50 DISKUS
Brand
00173069600•GlaxoSmithKline LLC
$3.1228
per EA
ADVAIR 500-50 DISKUS
Brand
00173069700•GlaxoSmithKline LLC
$4.2290
per EA
XOPENEX HFA 45 MCG INHALER
Brand
27437005601•Lupin Pharmaceuticals Inc.
$5.0542
per GM
BREO ELLIPTA 200-25 MCG INHALR
Brand
00173088214•GlaxoSmithKline LLC
$5.3628
per EA
BREO ELLIPTA 100-25 MCG INHALR
Brand
00173085914•GlaxoSmithKline LLC
$5.3663
per EA
BREO ELLIPTA 50-25 MCG INHALER
Brand
00173091610•GlaxoSmithKline LLC
$6.4848
per EA